your market intelligence analyst
Search Results
351 results
Your search is now limited to «Vaccines» expert search. 11/14/2019 11:09
Intratumoral accumulation of T-cells recognizing vaccine-encoded TAAs will be determined before vaccination in a tumor biopsy and after the 3 cycles of chemotherapy and the 5th vaccination using tumor tissue derived from interval surgery.
More from
ENDPOINTS 11/14/2019 10:33
Its second program, personalized cancer vaccines equipped with patient-specific neoantigens, is set for the clinic in 2020.
More from ENDPOINTS:
GlobeNewswire 11/14/2019 09:00
GeoVax’s current development programs are focused on preventive vaccines against HIV, Zika Virus, hemorrhagic fever viruses (Ebola, Sudan, Marburg, and Lassa), and malaria, as well as therapeutic vaccines against chronic Hepatitis B infections and multiple cancers.
More from GlobeNewswire:
Financial Post (Canada) 11/14/2019 08:00
– Novel recombinant, protein-based immuno-therapeutic for the treatment of chronic hepatitis B virus (HBV) infection – Two-part, dose-escalation study expected to enroll up to 65 patients – Initial data expected in H2 2020 CAMBRIDGE, Mass. & BEIJING & DURHAM, N.C. — VBI Vaccines (NASDAQ: VBIV) ("VBI"), a commercial-stage biopharmaceutical company developing next-generation infectious disease and [...]
More from Financial Post (Canada):
Business Wire 11/14/2019 08:00
Integrating its cytomegalovirus (CMV) expertise with the eVLP platform technology, VBI’s lead eVLP program candidates include a prophylactic CMV vaccine candidate and a glioblastoma (GBM) vaccine immunotherapeutic candidate.
More from Business Wire:
Medical Xpress - Cancer News 11/14/2019 07:59
Researchers find simpler, more effective cancer vaccine approach.
More from Medical Xpress - Cancer News: 11/14/2019 01:32
Although HPV vaccines have been available since 2006, the incidence of precancerous lesions (cervical intraepithelial neoplasia or CIN) and cervical cancer due to HPV has not decreased substantially.
More from 11/13/2019 03:17
The package insert for GSK’s MMRV vaccine clearly reveals that this jab’s four main viruses are all produced separately in either chick embryo cells (mumps and measles) or MRC-5 human diploid cells (rubella and varicella), the latter set being the identified cancer-causing culprit ...
More from
Cancer Network 11/13/2019
I think we’re all still waiting for that next big breakthrough, the next big leap forward, whether it is immune checkpoints or inflammatory agonists or other combinations for where immunotherapy will transform cancer treatment.
More from Cancer Network:
FP Trading Desk (Canada) 11/11/2019 21:50
Clinical trial collaboration agreement leverages NEC’s cutting-edge AI technology and VAXIMM’s novel oral T-cell immunotherapy technology NEC to make an equity investment in VAXIMM TOKYO & BASEL, Switzerland & MANNHEIM, Germany — NEC Corporation (NEC; TOKYO: 6701), a leader in IT and network technologies, and VAXIMM AG, a Swiss/German biotech company focused on developing oral [...]
PR Newswire 11/11/2019 11:58
It's estimated that the therapeutic cancer vaccine market alone will reach more than $15 billion by 2025.
More from PR Newswire:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications